Published in J Immunol on May 15, 1999
Gemfibrozil, a lipid-lowering drug, inhibits the induction of nitric-oxide synthase in human astrocytes. J Biol Chem (2002) 1.28
PPAR Regulation of Inflammatory Signaling in CNS Diseases. PPAR Res (2008) 1.11
Stat4 isoforms differentially regulate inflammation and demyelination in experimental allergic encephalomyelitis. J Immunol (2008) 0.98
IL-7Rα confers susceptibility to experimental autoimmune encephalomyelitis. Genes Immun (2010) 0.97
Therapeutic efficacy of suppressing the Jak/STAT pathway in multiple models of experimental autoimmune encephalomyelitis. J Immunol (2013) 0.97
Quercetin, a flavonoid phytoestrogen, ameliorates experimental allergic encephalomyelitis by blocking IL-12 signaling through JAK-STAT pathway in T lymphocyte. J Clin Immunol (2004) 0.97
COX-2 inhibitors modulate IL-12 signaling through JAK-STAT pathway leading to Th1 response in experimental allergic encephalomyelitis. J Clin Immunol (2006) 0.95
JAK2 activates TFII-I and regulates its interaction with extracellular signal-regulated kinase. Mol Cell Biol (2001) 0.94
Gamma interferon and lipopolysaccharide interact at the level of transcription to induce tumor necrosis factor alpha expression. Infect Immun (2001) 0.93
The chemokine receptor antagonist, TAK-779, decreased experimental autoimmune encephalomyelitis by reducing inflammatory cell migration into the central nervous system, without affecting T cell function. Br J Pharmacol (2009) 0.86
Suppression of neuro inflammation in experimental autoimmune encephalomyelitis by glia maturation factor antibody. Brain Res (2010) 0.85
Involvement of the janus kinase/signal transducer and activator of transcription signaling pathway in multiple sclerosis and the animal model of experimental autoimmune encephalomyelitis. J Interferon Cytokine Res (2014) 0.83
Overexpression of glia maturation factor reinstates susceptibility to myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis in glia maturation factor deficient mice. Neurobiol Dis (2010) 0.82
Tyrphostin AG490 agent modestly but significantly prevents onset of type 1 in NOD mouse; implication of immunologic and metabolic effects of a Jak-Stat pathway inhibitor. J Clin Immunol (2012) 0.82
STAT4 controls GM-CSF production by both Th1 and Th17 cells during EAE. J Neuroinflammation (2015) 0.82
The tyrphostin agent AG490 prevents and reverses type 1 diabetes in NOD mice. PLoS One (2012) 0.80
Jaks and stats as therapeutic targets. Ann Rheum Dis (2000) 0.79
Protein Alpha Shape Similarity Analysis (PASSA): a new method for mapping protein binding sites. Application in the design of a selective inhibitor of tyrosine kinase 2. J Comput Aided Mol Des (2002) 0.78
Tyrosine kinase inhibitor tyrphostin AG490 retards chronic joint inflammation in mice. Inflammation (2014) 0.77
Histamine affects STAT6 phosphorylation via its effects on IL-4 secretion: role of H1 receptors in the regulation of IL-4 production. Int Immunopharmacol (2006) 0.76
Influence of Tyrphostin AG490 on the expression of diabetes-associated markers in human adipocytes. Immunogenetics (2012) 0.75
Opportunities for Translation from the Bench: Therapeutic Intervention of the JAK/STAT Pathway in Neuroinflammatory Diseases. Crit Rev Immunol (2015) 0.75
mCRY1 and mCRY2 are essential components of the negative limb of the circadian clock feedback loop. Cell (1999) 8.38
Interacting molecular loops in the mammalian circadian clock. Science (2000) 6.90
Structural basis of IAP recognition by Smac/DIABLO. Nature (2001) 3.66
Structural and biochemical basis of apoptotic activation by Smac/DIABLO. Nature (2000) 3.54
Undergraduate research. Genomics Education Partnership. Science (2008) 3.45
Prevention of type II collagen-induced arthritis by in vivo treatment with anti-L3T4. J Exp Med (1985) 2.92
CSF oligoclonal bands in MS include antibodies against Chlamydophila antigens. Neurology (2001) 2.88
Neuronal and glial apoptosis after traumatic spinal cord injury. J Neurosci (1997) 2.88
T cells responsive to myelin basic protein in patients with multiple sclerosis. Science (1990) 2.77
Reversal of experimental allergic encephalomyelitis with monoclonal antibody to a T-cell subset marker. Science (1985) 2.68
Natural killer T cell activation protects mice against experimental autoimmune encephalomyelitis. J Exp Med (2001) 2.67
Successful treatment of experimental allergic encephalomyelitis with transforming growth factor-beta 1. J Immunol (1991) 2.52
Presentations and outcomes of neurosarcoidosis: a study of 54 cases. QJM (2009) 2.49
Retrovirus-mediated gene transfer of MLL-ELL transforms primary myeloid progenitors and causes acute myeloid leukemias in mice. Proc Natl Acad Sci U S A (2000) 2.19
Carboxyfullerenes as neuroprotective agents. Proc Natl Acad Sci U S A (1997) 2.05
In vivo effects of antibodies to immune response gene products: prevention of experimental allergic encephalitis. Proc Natl Acad Sci U S A (1981) 2.00
Chromatin-related properties of CBP fused to MLL generate a myelodysplastic-like syndrome that evolves into myeloid leukemia. EMBO J (2000) 1.87
Interaction of Escherichia coli MutS and MutL at a DNA mismatch. J Biol Chem (2001) 1.77
Successful therapy of Theiler's virus-induced demyelination (DA strain) with monoclonal anti-Lyt-2 antibody. J Immunol (1988) 1.72
Adult Apaf-1-deficient mice exhibit male infertility. Dev Biol (2000) 1.70
Enteric inhibitory neural regulation of human colonic circular muscle: role of nitric oxide. Gastroenterology (1993) 1.54
Relationship of cesarean delivery to lower birth weight-specific neonatal mortality in singleton breech infants in the United States. Obstet Gynecol (1998) 1.53
A time-less function for mouse timeless. Nat Neurosci (2000) 1.53
DFF45/ICAD can be directly processed by granzyme B during the induction of apoptosis. Immunity (2000) 1.52
In vivo therapy with monoclonal anti-I-A antibody suppresses immune responses to acetylcholine receptor. Proc Natl Acad Sci U S A (1983) 1.52
The elongation domain of ELL is dispensable but its ELL-associated factor 1 interaction domain is essential for MLL-ELL-induced leukemogenesis. Mol Cell Biol (2001) 1.40
Anti I-A antibody suppresses active encephalomyelitis: treatment model for diseases linked to IR genes. J Exp Med (1983) 1.37
The Phe-X-Glu DNA binding motif of MutS. The role of hydrogen bonding in mismatch recognition. J Biol Chem (2001) 1.37
Cocaine-induced cortical microischemia in the rodent brain: clinical implications. Mol Psychiatry (2011) 1.31
Characterization of T cell lines and clones from SJL/J and (BALB/c x SJL/J)F1 mice specific for myelin basic protein. J Immunol (1985) 1.31
Bacillus thuringiensis HD-73 Spores Have Surface-Localized Cry1Ac Toxin: Physiological and Pathogenic Consequences. Appl Environ Microbiol (1996) 1.27
Suppression of murine collagen-induced arthritis with monoclonal anti-Ia antibodies and augmentation with IFN-gamma. J Immunol (1988) 1.26
MicroRNA-409 suppresses tumour cell invasion and metastasis by directly targeting radixin in gastric cancers. Oncogene (2011) 1.22
Nitric oxide: mediator of nonadrenergic noncholinergic responses of opossum esophageal muscle. Am J Physiol (1991) 1.20
Identification of T cell subsets and B lymphocytes in mouse brain experimental allergic encephalitis lesions. J Immunol (1982) 1.19
Failure to identify alveolar echinococcosis in trappers from South Dakota in spite of high prevalence of Echinococcus multilocularis in wild canids. J Parasitol (2000) 1.19
A GFP reporter system to assess gene transfer and expression in human hematopoietic progenitor cells. Gene Ther (1997) 1.16
Complete development of Cryptosporidium parvum in bovine fallopian tube epithelial cells. Infect Immun (1996) 1.16
Activity and autophosphorylation of LAMMER protein kinases. J Biol Chem (1996) 1.15
Occupational exposure to benzene in China. Br J Ind Med (1987) 1.14
Postinfectious and postvaccinial encephalomyelitis. Neurol Clin (1984) 1.13
Expression of IL-12 in CNS and lymphoid organs of mice with experimental allergic encephalitis. J Neuroimmunol (1998) 1.12
Conservation of cys-cys trp structural triads and their geometry in the protein domains of immunoglobulin superfamily members. Mol Immunol (1999) 1.10
Regulation of microglial activation by TGF-beta, IL-10, and CSF-1. J Leukoc Biol (1996) 1.06
Genomic organization of the human retinoblastoma gene. Oncogene (1989) 1.04
Interferon-beta 1b treatment decreases tumor necrosis factor-alpha and increases interleukin-6 production in multiple sclerosis. Neurology (1996) 1.04
Antigen-specific therapy of experimental allergic encephalomyelitis by soluble class II major histocompatibility complex-peptide complexes. Proc Natl Acad Sci U S A (1991) 1.04
Mechanism of inhibition of LPS-induced IL-12p40 production by IL-10 and TGF-beta in ANA-1 cells. J Leukoc Biol (1998) 1.03
Inhibitors of histone deacetylases promote hematopoietic stem cell self-renewal. Cytotherapy (2004) 1.03
Experimental allergic encephalomyelitis: neutralizing antibody to TGF beta 1 enhances the clinical severity of the disease. J Neuroimmunol (1993) 1.03
TGF-beta inhibits IL-12-induced activation of Jak-STAT pathway in T lymphocytes. J Immunol (1998) 1.03
The immunology of multiple sclerosis and its animal model, experimental allergic encephalomyelitis. Neurol Clin (1995) 1.02
Administration of dehydroepiandrosterone suppresses experimental allergic encephalomyelitis in SJL/J mice. J Immunol (2001) 1.01
Anti-CD22-MCC-DM1: an antibody-drug conjugate with a stable linker for the treatment of non-Hodgkin's lymphoma. Leukemia (2010) 1.01
Enamel proteases reduce amelogenin-apatite binding. J Dent Res (2008) 1.01
Ischemic dysfunction in transgenic mice expressing troponin I lacking protein kinase C phosphorylation sites. Am J Physiol Heart Circ Physiol (2001) 1.01
Murine model for pertussis vaccine encephalopathy: linkage to H-2. Nature (1982) 1.00
TGF-beta inhibits IL-2-induced tyrosine phosphorylation and activation of Jak-1 and Stat 5 in T lymphocytes. J Immunol (1997) 0.98
T2D-Db: an integrated platform to study the molecular basis of Type 2 diabetes. BMC Genomics (2008) 0.98
Failure to detect Chlamydia pneumoniae in the central nervous system of patients with MS. Neurology (2000) 0.98
Animal models of picornavirus-induced autoimmune disease: their possible relevance to human disease. Lab Invest (1990) 0.97
Chlamydia pneumoniae infection of the central nervous system. Curr Opin Neurol (2001) 0.96
Non-invasive image acquisition and advanced processing in optical bioimaging. Comput Med Imaging Graph (1998) 0.96
Sputum endothelin-1 is increased in cystic fibrosis and chronic obstructive pulmonary disease. Eur Respir J (1999) 0.96
Prevention of experimental allergic encephalomyelitis via inhibition of IL-12 signaling and IL-12-mediated Th1 differentiation: an effect of the novel anti-inflammatory drug lisofylline. J Immunol (1998) 0.96
Sustained gene expression in retrovirally transduced, engrafting human hematopoietic stem cells and their lympho-myeloid progeny. Blood (1998) 0.94
Chloroform extract of Carica papaya seeds induces long-term reversible azoospermia in langur monkey. Asian J Androl (2002) 0.94
Treatment of established chronic relapsing experimental allergic encephalomyelitis with anti-L3T4 antibodies. J Immunol (1986) 0.93
Infection of immunosuppressed C57BL/6N adult mice with a single oocyst of Cryptosporidium parvum. J Parasitol (2000) 0.93
Infectivity of preserved Cryptosporidium parvum oocysts for immunosuppressed adult mice. FEMS Immunol Med Microbiol (1996) 0.92
Therapeutic efficacy of paromomycin in immunosuppressed adult mice infected with Cryptosporidium parvum. J Parasitol (1995) 0.92
Long-term treatment of chronic relapsing experimental allergic encephalomyelitis by transforming growth factor-beta 2. J Neuroimmunol (1993) 0.92
Anticandidal activity of Santolina chamaecyparissus volatile oil. J Ethnopharmacol (1997) 0.92
Heat shock protein 27 mediates repression of androgen receptor function by protein kinase D1 in prostate cancer cells. Oncogene (2009) 0.91
Cycloheximide reduces infarct volume when administered up to 6 h after mild focal ischemia in rats. Brain Res (2001) 0.91
Role of community pharmacists in improving knowledge and glycemic control of type 2 diabetes. Perspect Clin Res (2012) 0.91
Mixed epithelial stromal tumor of the kidney. Indian J Urol (2011) 0.90
TGF-beta 2 decreases migration of lymphocytes in vitro and homing of cells into the central nervous system in vivo. J Immunol (1995) 0.90
Haplotype-specific suppression of experimental allergic encephalomyelitis with anti-IA antibodies. J Immunol (1987) 0.90
Decreased renal ischemia-reperfusion injury by IL-16 inactivation. Kidney Int (2007) 0.90
Is Chlamydia pneumoniae found in spinal fluid samples from multiple sclerosis patients? Conflicting results. Mult Scler (2002) 0.89
Soluble MHC II-peptide complexes induce antigen-specific apoptosis in T cells. Cell Immunol (1996) 0.88
In vivo immunomodulation by monoclonal anti-L3T4. 1. Effects on humoral and cell-mediated immune response. Cell Immunol (1987) 0.88
Mechanical stimulation effects on functional end effectors in osteoblastic MG-63 cells. J Biomech (2005) 0.88
Prevention of experimental allergic encephalitis with in vivo administration of anti I-A antibody. Decreased accumulation of radiolabelled lymph node cells in the central nervous system. J Neuroimmunol (1983) 0.88
In vivo modulation of murine collagen induced arthritis. Int Rev Immunol (1988) 0.87
Genetic control of multisystem autoimmune disease in encephalomyocarditis virus infected BALB/cCUM and BALB/cBYJ mice. Curr Top Microbiol Immunol (1985) 0.87
Superantigens augment antigen-specific Th1 responses by inducing IL-12 production in macrophages. J Leukoc Biol (1999) 0.87
Efficacy trial on the purified compounds of the seeds of Carica papaya for male contraception in albino rat. Reprod Toxicol (2005) 0.87
Indirect role of T cells in development of polioencephalitis and encephalomyelitis induced by encephalomyocarditis virus. J Virol (1991) 0.87
Guanylate cyclase inhibitors: effect on tone, relaxation, and cGMP content of lower esophageal sphincter. Am J Physiol (1992) 0.86
Not by bread alone': impact of a structured 90-minute play session on development of children in an orphanage. Child Care Health Dev (2002) 0.86
Guanylate cyclase inhibitors: effect on inhibitory junction potentials in esophageal smooth muscle. Am J Physiol (1992) 0.86
Efficacy of serine protease inhibitors against Cryptosporidium parvum infection in a bovine fallopian tube epithelial cell culture system. J Parasitol (1996) 0.86
Gene-expression signatures: biomarkers toward diagnosing multiple sclerosis. Genes Immun (2011) 0.85
Analysis of TCR V beta gene usage and encephalitogenicity of myelin basic protein peptide p91-103 reactive T cell clones in SJL mice: lack of evidence for V gene hypothesis. Cell Immunol (1992) 0.85
Successful treatment of established relapsing experimental autoimmune encephalomyelitis in mice with a monoclonal natural autoantibody. J Neuroimmunol (1997) 0.85